Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
This empowers clinicians to make more informed, personalized decisions earlier in the disease course and access life-prolonging targeted radionuclide therapy for more patients with prostate cancer.
Some hospitals met these additional requirements by providing additional data that gave MRF users valuable understanding on how the payer-specific negotiated charge is calculated and enough information that innovators, employers, and researchers could then draw meaningful comparisons
Areas of Scientific Interest Researchers have investigated TB-500 in relation to: Cell migration Cellular differentiation Tissue remodelling pathways Actin regulation Recovery-related biological signalling Like BPC-157, TB-500 is supplied strictly for research and laboratory investigation
And this is exactly where the problem begins
10.1523/JNEUROSCI.3607-16.2017 J
others find it initially disruptive
US$ 23.67
US$ 26.98
